Since 1995, Reliable Business Intelligence for Clinical Laboratories, Pathology Groups and Laboratory Diagnostics

Invitae Cuts Costs to Rebuild Oncology Testing Pipeline

Divesture of assets and layoffs expected to result in nearly $100 million in savings

INVITAE CORPORATION, A MEDICAL GENETICS COMPANY that had a $1.34 billion loss during the nine months ending Sept. 30, 2023, recently announced coming actions to cut costs and change operations. The San Francisco-based company sold “certain reproductive health assets including carrier screening and non-invasive prenatal screening” to Natera, an Austin, Texas-based company offering cell-free DNA …

Invitae Cuts Costs to Rebuild Oncology Testing Pipeline Read More »

To access this post, you must purchase The Dark Report.



You are reading premium content from The Dark Report, your primary resource for running an efficient and profitable laboratory.

Get Unlimited Access to The Dark Report absolutely FREE!

You have read 0 of 1 of your complimentary articles this month

Privacy Policy: We will never share your personal information.